Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries

Brain Res. 1991 Dec 13;567(1):76-82. doi: 10.1016/0006-8993(91)91438-7.

Abstract

The muscarinic (M) receptors involved in the vasodilation elicited by acetylcholine (ACh) and in the carbachol inhibition in electrically induced [3H]noradrenaline (NA) release in cat cerebral arteries was investigated. For this, atropine, pirenzepine, AF-DX 116, 4-DAMP, non-specific, M1, M2 and M3 receptor antagonists, respectively, were used. ACh elicited concentration-dependent relaxations up to 10(-6) M which were attenuated by these antagonists; the order of potency (pA2 values) to inhibit the ACh-induced relaxation was: atropine (10.1) 4-DAMP (8.9) greater than pirenzepine (7.6) greater than AF-DX 116 (5.9). The electrical stimulation (200 mA, 0.3 ms, 2 Hz, during 1 min) of these arteries preincubated with [3H]NA caused tritium release which was inhibited by carbachol (10(-6) M). The 4 antagonists attenuated the action of the M agonist; the order of potency (pIC50 values) was: atropine (8.7) greater than 4-DAMP (8.1) greater than AF-DX 116 (7.9) greater than pirenzepine (5.8). The action of McN-A-343, a putative M1 agonist, was also investigated. This agent produced small vasodilator responses and elevated concentrations (5 x 10(-5) M) inhibited the stimulated NA release, which was partially antagonized by atropine (10(-7) M) and pirenzepine (10(-8) and 10(-7) M). These results suggest the existence of M3 and M2 receptors mediating the relaxation induced by ACh and the NA release inhibition evoked by carbachol, respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride / pharmacology
  • Acetylcholine / pharmacology*
  • Animals
  • Atropine / pharmacology
  • Carbachol / pharmacology
  • Cats
  • Cerebral Arteries / metabolism
  • Cerebral Arteries / physiology*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiology*
  • Female
  • In Vitro Techniques
  • Male
  • Muscle, Smooth, Vascular / metabolism
  • Muscle, Smooth, Vascular / physiology*
  • Norepinephrine / metabolism*
  • Parasympatholytics / pharmacology*
  • Parasympathomimetics / pharmacology*
  • Piperidines / pharmacology
  • Pirenzepine / analogs & derivatives
  • Pirenzepine / pharmacology
  • Receptors, Muscarinic / drug effects
  • Receptors, Muscarinic / metabolism
  • Receptors, Muscarinic / physiology*
  • Vasodilation / drug effects

Substances

  • Parasympatholytics
  • Parasympathomimetics
  • Piperidines
  • Receptors, Muscarinic
  • Pirenzepine
  • (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
  • Atropine
  • 4-diphenylacetoxy-1,1-dimethylpiperidinium
  • Carbachol
  • Acetylcholine
  • otenzepad
  • Norepinephrine